HZNP

Q: What is the price of Horizon Therapeutics (HZNP) today?

The price of Horizon Therapeutics (HZNP) today is $ 0.00, with return of 0% compared to the last year. The price of Horizon Therapeutics (HZNP) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Horizon Therapeutics (HZNP) and international markets.

Q: When does Horizon Therapeutics (HZNP) pay dividends?

Horizon Therapeutics (HZNP) did not distribute dividends in the last year.

Q: Is Horizon Therapeutics (HZNP) worth it?

Currently, Horizon Therapeutics (HZNP) is priced at $ 0.00, with a P/E of 62.12%, representando um desvio de 5,360% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Horizon Therapeutics (HZNP) stock?

Investing in stocks of Horizon Therapeutics (HZNP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Horizon Therapeutics (HZNP) yield today?

The yield of Horizon Therapeutics (HZNP) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Horizon Therapeutics (HZNP) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Horizon Therapeutics Public Limited Company

Price

$ -

return (12m)

0.00%

p/e

62.12

p/bv

5.12

DIVIDEND YIELD

0.00%

price HZNP

HZNP

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of HZNP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals HZNP

review the fundamentals of Horizon Therapeutics shares

P/E

62.12

Sector: -3.40 Industry: -3.40

P/SALES RATIO (PSR)

7.47

Sector: -3.36 Industry: -3.36

P/BV

5.12

Sector: 1.98 Industry: 1.98

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

4.71%

Sector: -62.78% Industry: -62.78%

ROE

8.25%

Sector: -68.26% Industry: -68.26%

ROIC

Sector: -1,140.39% Industry: -1,140.39%

NET MARGIN

12.02%

Sector: -41.80% Industry: -41.80%

GROSS MARGIN

75.21%

Sector: 39.33% Industry: 39.33%

OPERATING MARGIN

14.09%

Sector: -41.58% Industry: -41.58%

P/EBITDA

53.19

Sector: -3.48 Industry: -3.48

P/EBIT

222.15

Sector: -3.60 Industry: -3.60

P/ASSET

2.93

Sector: 1.42 Industry: 1.42

BVPS

22.70

Sector: 1.79 Industry: 1.79

EPS

1.87

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.57

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

10.62%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

2.36%

Sector: - Industry: -

FAIR VALUE OF Horizon Therapeutics ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals HZNP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.42	0.00	0.00%	2.51%	$ 487.73 B	27.26%
PFE	14.23	1.50	10.56%	6.95%	$ 139.89 B	15.65%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.73	7.92	57.70%	3.54%	$ 211.67 B	32.78%
MRK	12.83	0.00	0.00%	3.31%	$ 244.20 B	29.63%
AZN	30.03	6.14	20.45%	1.72%	$ 282.28 B	16.17%
BMY	15.59	5.06	32.47%	5.36%	$ 94.17 B	12.57%
GILD	19.41	7.34	37.80%	2.48%	$ 157.41 B	27.88%
ZTS	20.40	10.02	49.11%	1.58%	$ 54.07 B	28.21%
HALO	13.82	16.33	118.17%	0.00%	$ 8.23 B	47.91%
REGN	17.17	2.54	14.79%	0.35%	$ 78.61 B	32.13%
AMGN	25.92	18.88	72.82%	2.78%	$ 181.60 B	19.47%
VRTX	29.73	6.31	21.22%	0.00%	$ 109.25 B	31.35%
MCK	26.63	-185.79	-697.75%	0.34%	$ 107.39 B	1.04%
ADMA	19.60	9.52	48.57%	0.00%	$ 4.11 B	42.87%
CAH	31.26	-18.26	-58.40%	0.97%	$ 49.86 B	0.68%
BIIB	16.02	1.42	8.83%	0.00%	$ 25.77 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

HZNP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Horizon Therapeutics

Horizon Therapeutics Public Limited Company

Average user rating I10

4.0 (0 people)

United States

15 years

Founded: 2010

2011

Time since IPO - 14 years

1.395

Employees

The Company Horizon Therapeutics Public Limited Company (United States), is listed on Nasdaq with a market cap of $ 27.21 Billions, having an equity of $ 5.31 Billions.

With a total of 1.395 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 3.64 Billions, which generated a profit in the amount of $ 438.00 Millions.

As for its main indicators, the Company has a P/E ratio of 62.12, a P/BV ratio of 5.12 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker HZNP.

Market cap

$ 27.21 Billions

Equity

$ 5.31 Billions

US$ 5,310,959,000.00

Assets

$ 9.30 Billions

US$ 9,298,741,000.00

Total Shares Outstanding

233.94 Millions

233,935,000

Average Daily Trading Volume

$ 2.44 Millions

US$ 2,438,746.00

Sector

Health Care

Industry

Biotechnology

HZNP

HZNP revenue and profits

Financial Results HZNP

DRAG THE FRAME TO SEE MORE DATA

HZNP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 889.28 43,05% (12M)

P/E

26.63

0.34%

ROE

-697.75%

P/BV

-185.79

CAH - Cardinal Health

$ 213.73 77,50% (12M)

P/E

31.26

0.97%

ROE

-58.40%

P/BV

-18.26

JNJ - Johnson & Johnson

$ 206.67 39,00% (12M)

P/E

19.42

2.51%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 105.66 8,77% (12M)

P/E

12.83

3.31%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.72 8,48% (12M)

P/E

14.23

6.95%

ROE

10.56%

P/BV

1.50

ABBV - AbbVie

$ 231.80 32,43% (12M)

P/E

102.44

2.97%

ROE

-2,726.81%

P/BV

-2,793.44

AZN - AstraZeneca

$ 93.24 43,50% (12M)

P/E

30.03

1.72%

ROE

20.45%

P/BV

6.14

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 889.28 43,05% (12 M)

P/L

26.63

0.34%

ROE

-697.75%

P/VP

-185.79

CAH - Cardinal Health

$ 213.73 77,50% (12 M)

P/L

31.26

0.97%

ROE

-58.40%

P/VP

-18.26

JNJ - Johnson & Johnson

$ 206.67 39,00% (12 M)

P/L

19.42

2.51%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 105.66 8,77% (12 M)

P/L

12.83

3.31%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.72 8,48% (12 M)

P/L

14.23

6.95%

ROE

10.56%

P/VP

1.50

ABBV - AbbVie

$ 231.80 32,43% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

AZN - AstraZeneca

$ 93.24 43,50% (12 M)

P/L

30.03

1.72%

ROE

20.45%

P/VP

6.14

Frequently Asked Questions

What is the price of Horizon Therapeutics (HZNP) today?

The price of Horizon Therapeutics (HZNP) today is $ 0.00, with return of 0% compared to the last year. The price of Horizon Therapeutics (HZNP) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Horizon Therapeutics (HZNP) and international markets.

When does Horizon Therapeutics (HZNP) pay dividends?

Horizon Therapeutics (HZNP) did not distribute dividends in the last year.

Is Horizon Therapeutics (HZNP) worth it?

Currently, Horizon Therapeutics (HZNP) is priced at $ 0.00, with a P/E of 62.12%, representando um desvio de 5,360% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Horizon Therapeutics (HZNP) stock?

Investing in stocks of Horizon Therapeutics (HZNP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Horizon Therapeutics (HZNP) yield today?

The yield of Horizon Therapeutics (HZNP) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Horizon Therapeutics (HZNP) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

HZNP

Horizon Therapeutics Public Limited Company

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of HZNP

review the fundamentals of Horizon Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Horizon Therapeutics

Horizon Therapeutics Public Limited Company

United States

15 years

2011

1.395

PROFIT X PRICE HZNP

Financial Results HZNP

HZNP cash flow

asset growth - HZNP

HZNP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions